BIO-RAD LABORATORIES, INC. (NYSE:BIO) Files An 8-K Other Events
On December22, 2016, the Superior Court of California for the
County of Contra Costa issued an order in the action captioned
City of Riviera Beach General Employees Retirement System v.
Schwartz, et al., Case No. C-15-00140 (Cal. Super. Ct.)
granting preliminary approval, subject to further consideration
at the settlement hearing described below, to the proposed
settlement by and among the following parties: (i)plaintiff City
of Riviera Beach General Employees Retirement System, on behalf
of themselves and derivatively on behalf of Bio-Rad Laboratories,
Inc.; (ii)defendants Norman Schwartz, Alice N. Schwartz, Louis
Drapeau, Deborah J. Neff and Albert J. Hillman; and (iii)nominal
defendant Bio-Rad Laboratories, Inc. The settlement, if finally
approved, also will cause the dismissal with prejudice of a
related consolidated action filed in Delaware Chancery Court by
plaintiffs International Brotherhood of Electrical Workers Local
No.38 Pension Fund and Wayne County Employees Retirement System
captioned In re Bio-Rad Laboratories, Inc. Stockholder
Litigation, Consol. C.A. No.11387-VCS (Del. Ch.).
to the Courts order, the Court will hold a hearing for final
approval of the settlement on March2, 2017 at 9:00 a.m. at the
Superior Court of California for the County of Contra Costa,
Martinez Courthouse, 725 Court Street, Martinez, CA 94553. Any
objections to the settlement must be filed in writing with the
Court on or before February15, 2017.
Additional information concerning the terms of the proposed
settlement, the March2, 2017 hearing and the requirements for
objections to the settlement can be found in the Notice of
Proposed Settlement of Derivative Action, attached hereto as
Exhibit 99.1, and the Stipulation and Agreement of Settlement,
attached hereto as Exhibit 99.2.
ITEM9.01Financial Statements and Exhibits.
|99.1||Notice of Proposed Settlement of Derivative Action|
|99.2||Stipulation and Agreement of Settlement|
About BIO-RAD LABORATORIES, INC. (NYSE:BIO)
Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company’s Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world. BIO-RAD LABORATORIES, INC. (NYSE:BIO) Recent Trading Information
BIO-RAD LABORATORIES, INC. (NYSE:BIO) closed its last trading session down -0.64 at 182.72 with 73,838 shares trading hands.